MA47193A - SOLID DOSAGE FORMS OF BACE1 2-AMINO-6- (DIFLUOROMETHYL) -5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINE - Google Patents

SOLID DOSAGE FORMS OF BACE1 2-AMINO-6- (DIFLUOROMETHYL) -5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINE

Info

Publication number
MA47193A
MA47193A MA047193A MA47193A MA47193A MA 47193 A MA47193 A MA 47193A MA 047193 A MA047193 A MA 047193A MA 47193 A MA47193 A MA 47193A MA 47193 A MA47193 A MA 47193A
Authority
MA
Morocco
Prior art keywords
bace1
tetrahydropyridine
difluoromethyl
difluoro
phenyl
Prior art date
Application number
MA047193A
Other languages
French (fr)
Inventor
Karsten Juhl
Mauro Marigo
Lena Tagmose
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of MA47193A publication Critical patent/MA47193A/en

Links

MA047193A 2014-11-10 2015-11-09 SOLID DOSAGE FORMS OF BACE1 2-AMINO-6- (DIFLUOROMETHYL) -5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINE MA47193A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA201400648 2014-11-10

Publications (1)

Publication Number Publication Date
MA47193A true MA47193A (en) 2019-11-13

Family

ID=58688571

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047193A MA47193A (en) 2014-11-10 2015-11-09 SOLID DOSAGE FORMS OF BACE1 2-AMINO-6- (DIFLUOROMETHYL) -5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINE

Country Status (2)

Country Link
AR (1) AR102599A1 (en)
MA (1) MA47193A (en)

Also Published As

Publication number Publication date
AR102599A1 (en) 2017-03-08

Similar Documents

Publication Publication Date Title
NL301322I2 (en) Repotrectinib and/or pharmaceutically acceptable salts thereof
IL285114B1 (en) Aryl, heteroaryl, and heterocyclic compounds for the treatment of complement-mediated disorders
IL246833A0 (en) Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
MA41265A (en) COMPOSITIONS FOR THE ADMINISTRATION OF ILÉO-JEJUNAL DRUGS.
EP3274440A4 (en) DETECTION OF SOPHAGE DISORDERS
DK3119397T3 (en) Heterocyclic compounds for use in the treatment of PI3K-gamma-mediated disorders
EP3174874A4 (en) BERBERIN SALTS, URSODESOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF
DK3102213T3 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
PL3936130T3 (en) Valbenazine dosage regimen for the treatment of hyperkinetic movement disorders
IL252089A0 (en) 2-amino-6-(difluoromethyl)-5,5,-difluoro-6-phenyl-6,5,4,3-tetrahydropyridines as BACE1 inhibitors
BR112016021012A2 (en) pharmaceutical compositions of therapeutically active compounds.
HUE037179T2 (en) Pharmaceutical compositions for the treatment of muscle disorders
IL251859A0 (en) Methotrexate formulation
GB201401086D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
BR112017013012A2 (en) indenyl compounds, pharmaceutical compositions and medical uses thereof
PT3359146T (en) PHARMACEUTICAL COMPOSITIONS AND USES AGAINST LYSOSOMIC STORAGE DISORDERS
EP3344280A4 (en) BONE FORMATION
PL3426230T3 (en) SOLID DOSAGE FORMS OF VIGABATRIN
EP3387469A4 (en) DETERMINATION OF ELECTROFACES
LT3519050T (en) COMPOSITIONS FOR THE TREATMENT OF OPHTHALMOLOGICAL CONDITIONS
LT3244889T (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MYCOSE
DK3423081T3 (en) COMPOSITIONS FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASE
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
LT3148588T (en) N, N-BIS-2-MERCAPTOETHYLISOPHALAMIDE FOR THE TREATMENT OF PARKINSON'S DISEASE
HRP20182018T1 (en) PREPARATION OF THE SOLID GADOBENATE DIMEGLUMIN